NO20054798L - Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer - Google Patents

Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer

Info

Publication number
NO20054798L
NO20054798L NO20054798A NO20054798A NO20054798L NO 20054798 L NO20054798 L NO 20054798L NO 20054798 A NO20054798 A NO 20054798A NO 20054798 A NO20054798 A NO 20054798A NO 20054798 L NO20054798 L NO 20054798L
Authority
NO
Norway
Prior art keywords
lifestyle
related diseases
foods
preparation
prevention
Prior art date
Application number
NO20054798A
Other languages
English (en)
Other versions
NO20054798D0 (no
Inventor
Tatsumasa Mae
Hideyuki Kishida
Toshinori Ikehara
Naoki Arai
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of NO20054798D0 publication Critical patent/NO20054798D0/no
Publication of NO20054798L publication Critical patent/NO20054798L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Det er tilveiebrakt et preparat for å forebygge og/eller forbedre livsstilsrelaterte sykdommer som inneholder minst en forbindelse valgt fra gruppen som består av glabren, glabridin, glabrol, 3'-hydroksy- 4'-0-metylglabridin, 4'-0-metylglabridin og hyspaglabridin, som er forbindelser med en PPARy hgand aktivitet og som er effektive for å forbedre insulinresistens og for å forebygge og/eller forbedre livsstilsrelaterte sykdommer slik som visceralt fett-obesitas, type 2 diabetes, hyperlipemi og hypertensjon og som kan anvendes i næringsmidler og drikkevarer (feks. helsekost og næringsmidler med helsekrav), legemidler, kvasilegemidler eller kosmetikk, eller et preparat for å regulere og/eller forbedre kroppsvekt.
NO20054798A 2003-07-31 2005-10-18 Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer NO20054798L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003204275 2003-07-31
PCT/JP2004/010381 WO2005011672A1 (ja) 2003-07-31 2004-07-14 生活習慣病予防・改善用の油脂加工組成物

Publications (2)

Publication Number Publication Date
NO20054798D0 NO20054798D0 (no) 2005-10-18
NO20054798L true NO20054798L (no) 2006-01-31

Family

ID=34113638

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054798A NO20054798L (no) 2003-07-31 2005-10-18 Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer

Country Status (11)

Country Link
US (1) US20070098761A1 (no)
EP (1) EP1649854A1 (no)
JP (1) JPWO2005011672A1 (no)
KR (1) KR20060119706A (no)
CN (1) CN1777420A (no)
AU (1) AU2004261089A1 (no)
CA (1) CA2526589A1 (no)
NO (1) NO20054798L (no)
RU (1) RU2005126140A (no)
TW (1) TW200513194A (no)
WO (1) WO2005011672A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041876A1 (en) * 2005-03-30 2009-02-12 Kaneka Corporation Oil/fat-containing composition for suppression of carcinogenesis
WO2007058480A1 (en) * 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
WO2007060992A1 (ja) * 2005-11-25 2007-05-31 Kaneka Corporation メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤
TW200806306A (en) * 2006-02-24 2008-02-01 Kaneka Corp Oil-in-water emulsion composition containing licorice-derived polyphenol
TW200808333A (en) 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation
US20080286254A1 (en) * 2007-05-17 2008-11-20 Kaneka Corporation Composition comprising licorice polyphenol
US20090042813A1 (en) * 2007-08-10 2009-02-12 Sergey Michailovich Melnikov Hoodia extract oil compositions comprising medium chain triglycerides
US20110123505A1 (en) * 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
US9943560B2 (en) 2010-02-06 2018-04-17 James Zhou Medical compositions containing liquorice extracts with synergistic effect
JP2011231057A (ja) * 2010-04-28 2011-11-17 Kao Corp セラミド産生促進剤
CN102771673A (zh) * 2012-08-14 2012-11-14 江苏美迪森生物医药有限公司 一种构建代谢综合症动物模型的高脂纯化饲料及加工工艺
PL3480200T3 (pl) * 2016-06-29 2023-01-30 Glaceum, Inc. Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca
CN111713503A (zh) * 2020-07-16 2020-09-29 江苏省中国科学院植物研究所 两种异黄酮类化合物在防治植物病害中的用途
JP7792645B2 (ja) * 2020-10-07 2025-12-26 株式会社カネカ トランスサイレチン四量体安定化剤、及び、トランスサイレチンアミロイドーシス予防剤又は進行抑制剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794433B2 (ja) * 1989-02-02 1998-09-03 丸善製薬株式会社 甘草疎水性フラボノイド製剤
JP4418550B2 (ja) * 1999-02-17 2010-02-17 丸善製薬株式会社 疎水性甘草エキス含有組成物
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
EP1440688A4 (en) * 2001-10-11 2005-11-30 Kaneka Corp PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGANDS AND METHOD OF MANUFACTURING THE SAME
AU2003211636A1 (en) * 2002-03-04 2003-09-16 The Nisshin Oillio Group, Ltd Body temperature elevating agents
JP4191420B2 (ja) * 2002-03-26 2008-12-03 株式会社カネカ 甘草疎水性抽出物を含有してなる食用油脂組成物

Also Published As

Publication number Publication date
CN1777420A (zh) 2006-05-24
JPWO2005011672A1 (ja) 2006-10-19
AU2004261089A1 (en) 2005-02-10
US20070098761A1 (en) 2007-05-03
TW200513194A (en) 2005-04-16
WO2005011672A1 (ja) 2005-02-10
KR20060119706A (ko) 2006-11-24
CA2526589A1 (en) 2005-02-10
RU2005126140A (ru) 2006-02-10
EP1649854A1 (en) 2006-04-26
NO20054798D0 (no) 2005-10-18

Similar Documents

Publication Publication Date Title
NO20054798L (no) Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer
Yin et al. Effects of lycopene on metabolism of glycolipid in type 2 diabetic rats
Reinbach et al. Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance
JP5638180B2 (ja) サラシア属植物の抽出物とフラボノイドを含有する食品
IL215834A (en) Composition for strengthening human liquid milk @@ hmf @@ containing @ between @@@@@ and @@@@@ from a protein of high calorie density and from @@@@@@ to @@@ kak @@ to @ m @@ to
WO2011078677A3 (en) Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
JP2012500201A5 (no)
TW200740379A (en) Nutrition for obese patients
JP5503125B2 (ja) 内臓脂肪蓄積抑制剤
Shastun et al. Can functional food security decrease the epidemic of obesity and metabolic syndrome? A viewpoint
NO20065748L (no) Middel for forebygging/bedring av livstils-relaterte sykdommer som inneholder eterisk olje-komponent fra gurkemeie
IL172916A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
KR102127703B1 (ko) 타트체리추출물 및 미배아발효추출물을 유효성분으로 포함하는 우울증 또는 불안증 예방, 개선 또는 치료용 조성물
Pari et al. Antihyperglycemic and antilipidperoxidative effects of flavanoid naringin in streptozotocin-nicotinamide induced diabetic rats
TW200612903A (en) Use of trisubstituted benzopyranones
Rawat et al. Holistic approach during a pandemic for healthy well-being
KR20180053032A (ko) 신규한 피페린 유도체 및 이를 포함하는 약학적 조성물
WO2011145909A2 (ko) 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 근육 증가 촉진, 항-피로 및 운동수행능력 향상에 관한 새로운 용도
TW200823219A (en) ACAT inhibitor
KR100406837B1 (en) Health food composition containing natural product extract for reducing blood glucose level through the promotion of insulin release
JP2010030950A (ja) メタボリックシンドローム予防・治療剤ならびに機能性食品
TR200501978T2 (tr) Epigallokatesin galat içeren nutrasötik kompozisyonlar
JP2012162472A (ja) 脂質排泄促進剤
JP5801572B2 (ja) ＰＰＡＲγ活性化剤
CA2613041A1 (en) Agent for improving insulin resistance

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application